BRCA gene mutations significantly increase the risk of breast, ovarian, and other cancers. Identifying these mutations through genetic testing allows individuals and healthcare providers to take proactive steps for cancer prevention and early detection12. While BRCA mutations are rare in the general population, targeted testing based on personal or family history can provide crucial information for managing cancer risk3.
BRCA Gene Testing Explained
BRCA testing detects mutations in the BRCA1 and BRCA2 genes, which produce proteins essential for repairing damaged DNA and maintaining genome stability45. These genes act as tumor suppressors, preventing uncontrolled cell growth. Germline mutations (inherited changes present in all cells) in BRCA1 or BRCA2 impair DNA repair, leading to a significantly increased lifetime risk of breast and ovarian cancers, estimated between 45% and 85% for breast cancer and 10% to 45% for ovarian cancer by age 7026.
Besides breast and ovarian cancer, BRCA mutations also elevate risks for other cancers, including prostate, pancreatic, and melanoma7. The mutations follow an autosomal dominant inheritance pattern, meaning each child of a carrier has a 50% chance of inheriting the mutation8. However, not all carriers develop cancer, as the penetrance of these mutations is incomplete, and many cancers occur sporadically without BRCA mutations9.
Testing methods are highly accurate and include targeted mutation analysis and full gene sequencing performed in clinical laboratories1011. These tests analyze DNA from mcv blood test results meaning and normal range, saliva, or cheek swab samples to identify pathogenic variants10.
Who Needs BRCA Testing?
BRCA testing is recommended primarily for individuals at increased risk based on personal or family history. The U.S. Preventive Services Task Force (USPSTF) advises that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or those with ancestry associated with BRCA mutations3. Testing is not routinely recommended for the general population due to the low prevalence of mutations and cost considerations12.
Risk factors indicating the need for BRCA testing include:
- Personal history of breast cancer diagnosed before age 501314
- Multiple relatives with breast or ovarian cancer, especially bilateral breast cancer13
- Male breast cancer in the family7
- Known familial BRCA mutations15
- Ashkenazi Jewish ancestry, where mutation prevalence is higher (about 1 in 40 individuals)14
- Family history of pancreatic or prostate cancer7
Genetic counseling is an essential part of the testing process to evaluate risk and guide decision-making15.
BRCA Testing Benefits
BRCA testing provides valuable information for cancer risk stratification and personalized prevention strategies. Identifying mutation carriers allows for:
- Enhanced cancer screening, such as earlier and more frequent mammography and breast MRI, improving early detection10
- Risk-reducing surgeries, including bilateral mastectomy and salpingo-oophorectomy, which can reduce breast cancer risk by up to 90% and ovarian cancer risk by approximately 80%15
- Use of preventive medications like tamoxifen, which may lower breast cancer risk in BRCA2 mutation carriers16
- Informing family members about their potential risk, enabling cascade testing and preventive care15
Negative test results can provide reassurance and reduce anxiety but do not eliminate cancer risk, as many cases are sporadic26.
Potential Testing Risks
The physical risks of BRCA testing are minimal, primarily limited to minor discomfort or bruising from blood draws10. Saliva and cheek swab samples are non-invasive and risk-free10. However, psychological risks are significant and include anxiety, distress, and uncertainty following positive or inconclusive results2.
Preventive interventions based on test results carry their own risks:
- Surgical complications such as infection, bleeding, and thromboembolism from risk-reducing surgeries10
- Side effects from chemoprevention medications, including menopausal symptoms and increased risk of blood clots10
- Emotional challenges related to decision-making and coping with increased cancer risk2
Genetic counseling before and after testing helps manage these risks and supports informed choices15.
BRCA Testing Procedure
BRCA testing involves collecting a DNA sample, most commonly through a blood draw, but saliva or cheek swabs are also used10. The sample is sent to a laboratory where DNA is analyzed for mutations in the BRCA1 and BRCA2 genes using methods ranging from targeted mutation analysis to full gene sequencing10.
The testing process is straightforward:
- Sample collection (blood, saliva, or cheek swab)10
- Laboratory analysis of DNA for BRCA mutations10
- Results typically available within 1 to 3 weeks15
The test itself poses minimal physical risk. However, positive results may lead to complex decisions regarding preventive surgeries or medications, which carry medical risks210.
How to Get Tested
Testing at a Clinic
Clinical BRCA testing is considered the gold standard due to its accuracy and comprehensiveness. Testing in a clinical setting involves:
- Meeting with a healthcare provider or genetic counselor to discuss personal and family history15
- Providing a blood sample, usually drawn from a vein in the arm10
- Receiving professional genetic counseling before and after testing to understand implications and guide management15
- Results are typically returned within 1 to 3 weeks15
Clinical testing may include comprehensive gene panels that test for multiple cancer-related genes beyond BRCA1 and BRCA214.
Testing at Home
At-home BRCA testing kits offer convenience by allowing individuals to collect saliva or cheek swab samples and mail them to a laboratory10. However, these tests may:
- Cover only common mutations, missing less frequent or family-specific variants1215
- Yield false positives or negatives, requiring confirmatory clinical testing15
- Lack professional genetic counseling, which is important for interpreting results and planning care12
Professional societies recommend clinical testing over direct-to-consumer tests to ensure accuracy and proper guidance15.
Interpreting BRCA Results
Positive Results
A positive BRCA test indicates the presence of a harmful mutation that increases cancer risk but does not guarantee cancer development210. Mutation carriers often develop cancer at younger ages and may consider enhanced screening and preventive measures, including surgery and medication16.
Positive results also have implications for family members, who have a 50% chance of inheriting the mutation and may benefit from genetic testing and risk management815.
Negative Results
A negative test means no harmful BRCA mutation was detected. If a known familial mutation exists and the test is negative for that mutation, the individual’s cancer risk is similar to the general population, and they cannot pass the mutation to their children15. However, a negative result does not eliminate cancer risk entirely, especially if there is no known familial mutation or if other risk factors exist26.
Uncertain or Inconclusive Results
Sometimes, testing identifies a variant of uncertain significance (VUS), a gene change whose impact on cancer risk is unknown10. Most VUS are eventually reclassified as benign or harmful as more data become available. Until then, cancer risk management should be based on family history and other factors15.
Genetic counseling is critical to help understand and manage uncertain results15.
When to Contact Your Doctor
“It’s important to discuss your genetic test results with a genetics expert, such as a genetic counselor, and your doctors. They can offer guidance on what changes, if any, should be made in your care.”
— Hiam Abdel-Salam, MD Anderson16
You should contact your healthcare provider or genetic counselor:
- To discuss whether BRCA testing is appropriate based on your personal and family history3
- When you receive your test results, to understand their meaning and implications15
- If your results are positive or uncertain, to plan enhanced screening, preventive measures, and family communication16
- To address any emotional or psychological concerns related to testing and results2
Results typically take 1 to 3 weeks to return and are communicated during a follow-up visit or phone call15.
Key Takeaways
- BRCA1 and BRCA2 gene mutations significantly increase lifetime risk of breast, ovarian, and other cancers2.
- Testing is recommended for individuals with personal or family histories suggestive of hereditary breast and ovarian cancer, or certain ancestries such as Ashkenazi Jewish314.
- Positive test results enable personalized cancer prevention strategies, including enhanced screening and risk-reducing surgeries15.
- Genetic counseling before and after testing is essential to understand risks, benefits, and implications for family members15.
- At-home genetic tests may be convenient but lack comprehensiveness and professional guidance, making clinical testing preferable1215.
